Christophe Zemmour

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Journal: Cancer communications (London, England)

Published: November 23, 2025

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

Journal: ESMO open

Published: November 04, 2025

Pronostic factors for survival in candidemia among onco-hematology patients: a single-center retrospective study during 10 years.

Pronostic factors for survival in candidemia among onco-hematology patients: a single-center retrospective study during 10 years.

Journal: Journal de mycologie medicale

Published: March 28, 2025

Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors.

Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors.

Journal: Frontiers in endocrinology

Published: January 29, 2025

Short- and long-term impact of the TaTME learning process: a single institutional study.

Short- and long-term impact of the TaTME learning process: a single institutional study.

Journal: Techniques in coloproctology

Published: May 02, 2024

PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

Journal: The oncologist

Published: January 23, 2024

Safety of intrabiliary radiofrequency ablation in cases of residual and recurrent neoplasia after endoscopic papillectomy.

Safety of intrabiliary radiofrequency ablation in cases of residual and recurrent neoplasia after endoscopic papillectomy.

Journal: Endoscopy international open

Published: January 16, 2024

Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

Journal: Blood advances

Published: September 21, 2023

Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.

Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.

Journal: Journal for immunotherapy of cancer

Published: June 25, 2023

Assessment of biological effect of nab-paclitaxel combined with gemcitabine, using contrast enhanced ultrasonography and elastography, in advanced pancreatic ductal carcinoma: A single-center pilot study.

Assessment of biological effect of nab-paclitaxel combined with gemcitabine, using contrast enhanced ultrasonography and elastography, in advanced pancreatic ductal carcinoma: A single-center pilot study.

Journal: Endoscopic ultrasound

Published: May 06, 2023

A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.

A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 03, 2023

Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients.

Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients.

Journal: Cancers

Published: April 12, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026